Stock listing
VVOS Stock Price, News, Filings & Events — Vivos Therapeutics, Inc.
Selected listing: VVOS · BOATS · USD · US
This page tracks Vivos Therapeutics, Inc.'s VVOS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VVOS:BOATS. VVOS:BOATS is the stock-level entry point for investors researching Vivos Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vivos Therapeutics, Inc. is a public company traded under the ticker VVOS in the American market. The company has a market capitalization of approximately $5.46 million. Vivos focuses on developing innovative solutions for the treatment of sleep-disordered breathing and related conditions.
- Ticker
- VVOS:BOATS
- Asset type
- Stock
- Market cap
- $4.8M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BOATS
- Currency
- USD
Vivos Therapeutics, Inc. VVOS:BOATS stock context
This page tracks Vivos Therapeutics, Inc.'s VVOS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VVOS:BOATS. VVOS:BOATS is the stock-level entry point for investors researching Vivos Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vivos Therapeutics, Inc. is a public company traded under the ticker VVOS in the American market. The company has a market capitalization of approximately $5.46 million. Vivos focuses on developing innovative solutions for the treatment of sleep-disordered breathing and related conditions.
Latest news from Vivos Therapeutics, Inc.
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 25, 2026
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testin...
August 20, 2026
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
August 14, 2026
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
June 30, 2026
Research Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for VVOS:BOATS.
Vivos Therapeutics, Inc. company profile
View the public company page for Vivos Therapeutics, Inc. on 6ix.
Vivos Therapeutics, Inc. news
Read company news and market updates connected to Vivos Therapeutics, Inc..
Vivos Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Vivos Therapeutics, Inc..